Modelling Chemically-induced Seizures in Zebrafish:

A Holistic Review of Current Research Applications

 

Ponnala Namitha*, Jorige Archana

Department of Pharmacology, RBVRR Women’s College of Pharmacy,

Affiliated to Osmania University, Barkatpura, 3-4-343, Hyderabad, 500027, India.

*Corresponding Author E-mail: ponnalanamitha1602@gmail.com

 

ABSTRACT:

The neurological condition known as epilepsy affects both adults and children, and little is known about many facets of this illness. In addition to examining Zebrafish's potential as an epileptic research model, this review compares the numerous chemicals used to cause seizures in zebrafish models by evaluating gene expressions and behavioral patterns as indicators of seizure incidence. Their brains are rather simple, but compared to traditional rodent models, researchers can still gather a lot of data in a shorter length of time and for less money. With less ethical issues, this is especially helpful for screening a large number of potential anti-seizure medications. Chemical inducers are becoming essential instruments for carefully adjusting brain activity in carefully monitored studies. Pilocarpine, picrotoxin (PTX), kainic acid (KA), pentylenetetrazole (PTZ), and other compounds are among the chosen chemical inducers. They primarily work by changing neurotransmitter receptors at inhibitory or excitatory synapses, including GABA and glutamate, which aids in epileptogenesis. To duplicate different kinds of seizures, including temporal lobe epilepsy and status epilepticus, and to investigate the effects of chemical inducers on zebrafish development, a number of parameters can be changed. Despite the abundance of substitutes, many chemical inducers are still neglected in zebrafish research. It becomes essential to track gene expression indicators like c-fos, which indicates neural activity, in order to guarantee the effective induction of models. A grading system is also used to determine the effectiveness of treatment and assess the severity of seizures. Clarifying seizure pathways requires the use of chemically produced zebrafish seizure models, which greatly enhance neurological research.

 

KEYWORDS: Zebrafish, Epilepsy, Chemical Inducers, Pentylenetetrazole, Kainic Acid, Picrotoxin, Pilocarpine.

 

 


 

INTRODUCTION:

Recurrent seizures brought on by aberrant brain electrical activity are a hallmark of epilepsy, a neurological condition1. Although this neurological condition affects both adults and children, little is known about many of its characteristics. Zebrafish are perfect for researching neurological conditions that may lead to the development of treatments for epilepsy because of their well-preserved neural systems2,3. In contrast to traditional rodent models, researchers may gather a large amount of data at a reduced cost and in a shorter amount of time using zebrafish, despite their relatively rudimentary brain structure, and gain various insights into the etiology and management of epilepsy. This minimizes ethical concerns and is especially helpful when screening a large number of potential antiseizure medications (ASDs). In controlled research, chemical inducers have proven indispensable for regulating brain activity4. As a result, the majority of chemically induced models in aquatic vertebrates employ substances that throw off the animal's brain's equilibrium between inhibition and stimulation. Among the common chemical inducers are pilocarpine, picrotoxin (PTX), kainic acid (KA), pentylenetetrazole (PTZ), and others5. By evaluating behavioral patterns and gene expressions as biomarkers of seizure occurrence, this investigation seeks to thoroughly compare and analyze different chemicals utilized in zebrafish models to cause seizures. It also compares the variations between studies on epilepsy using adult and larvae zebrafish models.

 

Changing neurotransmitter receptors at excitatory or inhibitory synapses, especially those for GABA and glutamate is the main mechanism of these pharmacological inducers. By creating an inhibitory and excitatory imbalance of impulses in the brain, this alteration aids in epileptogenesis. In the zebrafish brain, the ensuing excitement causes metabolic disruption, neuronal death, and an increase in reactive oxygen species (ROS). Chemical induction provides important insights into the neurological functioning of zebrafish by enabling the observation of behaviors such as freezing, loss of posture, and whole-body contractions. To duplicate different kinds of seizures, including temporal lobe epilepsy, status epilepticus and to investigate effects of chemicals inducing seizures on zebrafish development, a number of parameters can be changed. To ensure the successful induction of models, it becomes crucial to monitor expression of gene indicators like c-fos, that reflects  brain activity. A grading system is also used for determine the effectiveness of treatment and assess the severity of seizures6.

 

For the first time, Baraban's group used zebrafish as a seizure model in 20057. That pioneering study's authors reported the zebrafish larvae PTZ model along with c-fos expression, behavioral activity and extracellular electrical activity as a gauge of brain activation. This laid the foundation for the subsequent modelling of epilepsy using zebrafish8.

 

ZEBRAFISH AS EPILEPSY MODELS:

Zebrafish General Features Making them Significant Models for Studying Epilepsy:

Zebrafish are members of the South Asian Phylum of chordates, the Subphylum Vertebrates, the class Osteichthyes, the order Cypriniformes, and the family Barbs. The embryo of this little teleost fish develops incredibly quickly, and as early as 24hours after fertilization (hpf), the entire body development plan is established. This quick development is similar to the first three months of a human embryo's intrauterine life9.

 

Zebrafish have been used as vertebrate model organisms in several studies on a variety of human diseases, including cancer, heart disease, and metabolic issues, since the 1980s10. Application of zebrafish to model and examine neurological disorders, including epilepsy and diseases related to neurodegeneration like Alzheimer’s and Parkinson’s, has grown significantly in the past ten years. Their unique characteristics, including as their short lifespan and quick generation period, genetic resemblance to humans, and less ethical restrictions than mammals (at least when it comes to larval stages), are probably the primary causes of this11. Since they allow for quick assessments of effectiveness and possible toxicity of novel drug compounds, zebrafish larvae and embryo have been popular in the past ten years as substitute preclinical models for screening and drug discovery in addition to being valuable for disease modelling12–13.

 

Like all vertebrates, zebrafish have three primary parts to their brains: Hindbrain/spinal cord, midbrain, and forebrain14. Adult brain regions like the pallium, sub-pallium, thalamus, and cerebellum are formed by the differentiation of cells from the embryonic forebrain, midbrain, and hindbrain15. As a result, most of the research to far has been on neurogenesis during the embryonic stages. The mature zebrafish brain, however, may also be a useful tool for researching adult neurogenesis, according to recent research16.

 

The CNS of zebrafish larvae is easily manipulable in experiments due to its outward development and optical transparency. A unique model organism for studying neurogenesis and epilepsy, the zebrafish integrates genetics, embryology, and cutting-edge optical techniques. It offers numerous benefits over its murine cousin, including quicker findings and cheaper pharmacological testing17.

 

Behavioral, genetic, pharmacological, and electrophysiological investigations have shown that zebrafish exhibit seizures that mimic many of the key features of seizures in mammals18, which makes them a great model organism for epilepsy research. Zebrafish larvae have been found to display a variety of motor behaviors like those observed in individuals with epilepsy, such as changed swimming pattern and body shaking. These behaviors are easily recognized and staged during seizure evaluation. Lastly, as previously said, zebrafish have a quick life cycle, which makes it possible to analyze several generations of seizures in a short amount of time.

 

 

Significance of Larvae Model Vs Adult Model of Zebrafish in studying Epilepsy:

All aforementioned properties make zebrafish larvae ideal for studying epilepsy; nevertheless, adult traits are still little understood. Zebrafish adults and larvae differ in several pathophysiological and pharmacological ways, which should be considered while studying epilepsy19.

 

First, as previously mentioned, adults have a fully formed brain that includes the blood-brain barrier (BBB) and has a complicated structure20. The peripheral and central neural systems, together with every other organ, undergo maturation during development from larvae to adult stage until they achieve physiological stability21.

 

Like that of mammals, the zebrafish BBB exhibits intricate organization and function22. Tight connections found in its endothelial cells are what give drugs their size-dependent permeability. At 3 dpf, the BBB formation begins, and by 14 dpf, it is nearly finished. Because of structural and functional maturation and changes of BBB of Zebrafish between the larval and juvenile phases, it ought to be considered that the consequences for epilepsy and effects of ASDs may differ between adults and larvae. It is crucial since the impact, cause, and management of seizures are all impacted by disturbance of the blood-brain barrier23.

 

As previously mentioned, neurogenesis differs in several ways between larvae and adults. In the former, it occurs in two stages, while in the latter, it is a vigorous process that encompasses every part of the brain. Furthermore, the two stages differ in how neural precursors are expressed. In addition, like animals, PTZ-induced seizures in adults encourage the growth of new neurons in a particular area of the dorsal telencephalon24. It implies that studying seizures in adult zebrafish could aid in comprehending the connection among epileptogenesis and neurogenesis.

 

Varied uptake and delivery of chemicals or medications from the external media is another distinction between adults and larvae that may be significant in research on epilepsy. Tiny pores in the chorion, a protective coat that envelops the larvae until 48- or 72hours post-fertilization, enable the passive absorption of drugs or treatments into the body. After 72hours after fertilization, the larvae can absorb the chemicals through their stomach, gills, and skin. During drug exposure, several embryos or larvae are treated simultaneously with varying amounts of drugs diluted in an embryo medium in a 24-well plate. While the adults are treated by dispersing drugs in tanks. Adult zebrafish will uptake drugs through their gills, skin, digestive tract. The BBB is completely developed in adults, though, so for the various substances or medications to reach their intended CNS targets, they must pass through this protective barrier25.

Since there are variations between larvae and adult zebrafish, this parameter should be considered throughout various epilepsy experiments, though the impact of gender difference on epilepsy is unclear. Sex hormones affect how ASDs are metabolized, how epilepsy develops, and how susceptible people, rats, and animals are to seizures26,27,28. It is difficult to identify the sex of zebrafish at larvae stage like 3 dpf because various genes may not be sufficiently expressed. As a result, gender differences can only be considered to exist in adult zebrafish. Gender differences can influence varied neuronal gene expression patterns and various functional or proliferative activity in specific brain areas in both male and female zebrafish29,30. Yet, when assessing zebrafish epilepsy, gender is a factor that is usually disregarded31,32.

 

Chemical Inducers of Epilepsy in Zebrafish

Pentylenetetrazole:

As antagonist of the GABA receptor, pentylenetetrazole (PTZ) is a tetrazole derivative33. To investigate seizure activity, PTZ, a pro-convulsant medication, is frequently utilized34. The quick inhibitory synaptic transmission known as GABAergic neurotransmission, which is mediated by GABA's communication with metabotropic and ionotropic membrane receptors, is what PTZ works by blocking. Following membrane depolarization, the interaction between PTZ and GABA-A receptors will block the chloride channel and decrease chloride ion influx. Pro-convulsant activity is facilitated by the action potentials produced by this depolarization, which raise neuronal excitability35,36,37. Additionally, at slightly negative to positive membrane potentials, PTZ encourages voltage-gated K+ channels to become inactive. Both the outward K+ current and the neurons' capacity to repolarize are diminished by the inactivation. Neuronal excitability, firing properties, and seizure activity production and maintenance may all be impacted by this modulation38. Epileptogenesis and the emergence of a propensity for recurrent seizures may result from these alterations, which could cause disturbance among inhibition and excitation in brain functioning39,40.

 

Drug screening, the development of anti-seizure therapies, and the detection of the negative consequences of seizure induction in pharmaceuticals for other illnesses have all benefited from the use of the PTZ zebrafish model41,42. This chemical kindling paradigm is a popular choice for experimental epilepsy research because of its many advantages, including its low mortality, ease of reproducibility, and lack of electrodes43. Larval zebrafish behavioral seizure activity can also be assessed by mixing PTZ with a regular bathing media. Larval behavioral traits have been extensively documented and applied to a variety of research techniques44.

 

Many genes have been investigated recently in the PTZ-induced zebrafish model. One important gene that is employed in this situation to confirm that seizures were successfully produced is c-fos. It is due to rapid appearance of c-fos, which is mainly located in zebrafish brain, in reaction to PTZ-like stimuli45,46. Furthermore, PTZ triggers the activation of bdnf-TrkB signalling pathway, which promotes inflammatory responses. The equilibrium between excitatory and inhibitory neurons may be upset by bdnf increase, notwithstanding the contentious link between it and epilepsy47,48. Due to blood-brain barrier leaking, PTZ-induced inflammation in the brain has been demonstrated to enhance additional inflammatory mediators, including NFκB, COX-2, IL-1β, and leukocyte infiltration49,50.

 

Kainic acid:

Kainic acid (KA) produces its neuroexcitatory effect by binding to AMPA or kainate receptors, which are ionotropic glutamate receptors with postsynaptic excitatory and presynaptic modulatory effects. To allow Ca2+ to enter the cell, KA binds to kainate receptors, activating the receptor and depolarizing the neuronal membrane. Calcium excess can cause neuronal injury and death by leading to generation of reactive oxygen species (ROS), that break down cell membranes, and disruption of cellular metabolism51,52. ROS, the oxidative stress mediators necessary for excitotoxic cell damage, were produced in greater quantities after KA induction due to intracellular calcium entry and glutamate receptor overactivation. Additionally, mitochondrial malfunction, glial activation, endoplasmic reticulum (ER) membrane fragmentation and ER stress, neuroinflammation, and neuronal death are all brought on by Ca2+ excess52,53.

 

Significant alterations in cell division and electrical activity, such as the induction of interictal events and protracted bursting discharges, can be brought on by KA. The developmental stage and length of exposure, however, may affect the effects of KA exposure. According to research by Menezes et al.54, early exposure to KA may have an impact on brain development and change a person's eventual sensitivity to seizures. These results emphasize how crucial it is to consider the developmental stage and exposure duration when examining how KA affects zebrafish behavior and brain function64. Additionally, KA influences astrocyte-related neurochemical alterations that cause a temporary decrease in GFAP cell and glutamate uptake levels as well as a sluggish swimming pattern in zebrafish56,57.

 

According to reports, KA administered directly to the pericardium causes severe inflammation and brain damage in the larval zebrafish model, resulting in seizure-like locomotor activity. Like the last study, brain cell death is indicated by KA-induced tissue opacity and elevated pro-apoptotic markers. Enhanced levels of pro-inflammatory cytokines, including IL-1β, fas, IL-8, TNF-α, IRF1-β, were also linked to the increased cell death, suggesting an acute inflammatory response like that seen in mammalian temporal lobe epilepsy (TLE). KA-induced locomotor abnormalities, which persist for several days after injection, include jerking movements, intermittent loss of posture, convulsion-like twitches, such as tail or fin twitches, and even whole-body waving. After that, the larvae lose their posture, become hypoactive during light-dark cycles, and become insensitive to tactile stimuli58.

 

Picrotoxin:

Animal models of epilepsy have been created using picrotoxin (PTX) which is non-competitive antagonist of the Gama-Amino Butyric Acid A (GABA-A) receptor, which carries chloride ions across cell membranes59,60. The GABA-C receptors, which are connected to the chloride channels, are also antagonistic to PTX; however, these receptors induce responses that are slow and sustained61. By lowering the receptor's opening frequency and mean open time, the PTX mechanism reduces the inhibitory impact of GABA62. Since PTX dissolves well in saltwater, it can be administered in any manner. As a result, seizures progress more slowly than those brought on by PTZ63.

 

When zebrafish are exposed to PTX, they display a range of behavioral alterations. Like PTZ, PTX has a dose-dependent effect on zebrafish locomotor activity64, 65. Large dosages of PTX cause zebrafish larvae to become more motile and exhibit thigmotaxis, a symptom of higher anxiety, in dark and light environments, according to a reported study. Compared to PTZ, PTX offers greater mobility in brighter light and reduced mobility in darker light66. Additionally, circular swimming, spasms, corkscrew swimming and spending more duration in the upper portion of tank are all signs of seizure-like behavior that increases with PTX exposure67.

 

Like PTZ, PTX also elicited an increase in neuronal excitability, a sign of the initiation of seizures, which led to an elevation of c-fos transcripts in the zebrafish embryo model after 30 minutes of treatment. In addition to c-fos, PTX causes the zebrafish brain to express more gabra1 and gabrg268.

 

Pilocarpine:

The hippocampus, striatum, and cortex are the main locations for pilocarpine, a non-selective muscarinic ACh receptor agonist69. In animal models, especially those for temporal lobe epilepsy (TLE), status epilepticus (SE), it is commonly employed to cause seizures. Action of pilocarpine involves activation of muscarinic M1 receptor. Once a seizure has begun, it is sustained by NMDA receptor activation70. Because of high concentration of muscarinic receptors, nucleus accumbens is major site of damage, and ventral forebrain is where seizures begin71. EEG recordings revealed a significant increase in hippocampus spike activity after pilocarpine treatment. A few hours after the seizure started, the brain damage started, and it got worse in some locations, like the neocortical areas and the hippocampus hilus72. However, pilocarpine research for seizures has been limited to rodents for years until recent studies investigated its potential use in adult           zebrafish73, 74.

 

A proposed method for assessing seizures in zebrafish produced by pilocarpine is a five-stage scoring system that mimics the swimming behavior of epileptic zebrafish75. A score like PTZ was used to rate zebrafish larvae in a study by Vermoesen et al.76. PTZ and pilocarpine-induced seizures in larval zebrafish were compared in Szep et al.'s work71. The study found that zebrafish larvae induced with pilocarpine exhibit more suppressed epileptiform activity than those induced with PTZ, hence decreasing the zebrafish's susceptibility to light. The mean total distance travelled was significantly smaller than that of the PTZ one71.

 

Table 1: Scoring of seizure severity based on behavior in variety of chemical induced models of epilepsy in Zebrafish.

Stage

Adult [PTZ, PTX]

Larvae [PTZ, PTX, Pilocarpine]

O

Short swim

Normal swimming

1

Enhanced swimming, frequency of opercular movement

Unsteady motion, increased swimming activity

2

Irregular movement

Whirl-pool like circling behavior

3

Circular movement

Brief clonus like spasms leading to posture loss

4

Clonic seizure behavior

Irregular burst movement with imbalance of posture

5

Tonic seizure behavior

 

6

Death

 

 


 

Table 2: Behavioral biomarkers and non-behavioral biomarkers expression in different chemically induced seizure models of zebrafish

Pentylenetetrazole [PTZ]

Strain/Age

Dose/Route

Behavioral biomarker

Non-behavioral biomarker

Reference

Larvae, AB line/4-5dpf

10,20,40mM PTZ immersed in water

increased locomotor activity

-

[45]

Adult, strain wild-type/ 3-4 months old

170 mg/kg i.p PTZ

Reached seizure score 4 within 150-180sec.á total distance travelled

â GABA

áGlutamate

âACh

âbdnf

ácreb1

[48]

Larvae, 7dpf

2.5,5,15 mM PTZ

Immersion in water

á Distance travelled

á Seizure score

á c-fos

[82]

Adult, Strain wild-type

10 mM

immersion

áSeizure score

ávelocity or swimming speed

á hsp 70 expression

âbdnf

ácreb

[83]

Larvae, 7dpf

1.25, 2.5, 5, 10, 20, 40, 80 mM PTZ, immersion

á Distance travelled

á Corkscrew swimming

ác-fos

âbdnf

[84]

 


Kainic acid [KA]

Strain/ Age

Dose/Route

Behavioral biomarker

Non-behavioral biomarker

Reference

Larvae, Wild-type, 3dpf

2.5, 5, 10 mg/kg

Pericardium microinjection

áswimming speed

átotal distance travelled

áearly apoptosis marker: caspase-9 and bax

áIL- 1β, IL- 8

ác4, csf1ra

 

[58]

Adult, strain wild-type, 6 months old

4,5,6 mg/kg i. p

increased seizure severity score

átotal distance travelled

áswimming speed

 

áGFAP

âGlutamate uptake in the forebrain

[56]

 


Picrotoxin [PTX]

Strain/Age

Dose/Route

Behavioral biomarker

Non-behavioral biomarker

Reference

Larvae, wild-type, 5dpf

1,5,25,125µM PTX immersed in water

increase in distance travelled

á c-fos

[66]

Larvae, wild-type, 5dpf

0-4mM PTX immersed in water

Concentration-dependent increase of seizure score

á distance travelled

ác-fos

[67]

 

Pilocarpine:

Age/Strain

Dose/Route

Behavioral biomarker

Non-behavior biomarker

Reference

Larvae, wild-type-5dpf

30mM/immersed in water

áTotal distance moved in light/dark

-

[77]

Adult, wild-type-AB stock

400mg/kg i. p

ámean seizure score

átotal distance travelled

ác-fos

âbdnf

áGlutamate

âGABA

âACh

[74]

 


Advantages and Disadvantages of Chemical Induction of Seizures in Zebrafish:

It is possible to replicate wide range of genetic and pharmacological seizures as seen in rodents, using zebrafish78. Chemically generated seizures in zebrafish models have several advantages. First, because the duration of the convulsions is determined by the concentration of the chosen convulsant, controlled studies and repeatable results are made possible. Additionally, chemical induction allows for the observation of behaviors like freezing, imbalance in posture, and whole-body contractions, providing crucial insights into the neurological activity of zebrafish. However, there are several significant disadvantages to employing drugs to cause seizures. One difficulty is the uncertainty in behavior interpretation, particularly the inability to distinguish between hyperactivity, abnormal behavior, seizure behavior in zebrafish larvae. One challenge in interpreting behavior in zebrafish larvae is the inability to distinguish clearly between seizure-like behavior, hyperactivity, and abnormal behavior. This challenge highlights the importance of closely examining behavior and accounting for potential confounding factors. Furthermore, only a limited number of chemical seizure models have been examined for non-behavioral seizure biomarkers, which limits the validity of identified effects. The size of adult zebrafish makes high-throughput studies more challenging, and the application of zebrafish for modelling is restricted, primarily to embryos and larvae79. Chemical induction has benefits in epilepsy research including animal models, such as PTZ, KA, pilocarpine, and PTX. These models replicate genuine seizure activity, advance our understanding of seizure mechanisms, and serve as valuable tools for upcoming therapeutic research80-82. There are limitations as well because these models may not fully capture the different pathways that underlie human seizures.

 

CONCLUSION:

In addition to helping create novel potential treatments for the human condition, experimental research in epilepsy offers the chance to reveal molecular mechanisms underlying excitability at neuronal level as well as provide insights into brain physiology. As a significant tool for processing data in a short span of duration with reduced expenses than traditional rodent models, without sacrificing a lot of potentially significant information, zebrafish are becoming a classic model in epilepsy research. Future studies on epilepsy should consider the distinct traits of zebrafish adults and larvae, as well as the numerous advantages and disadvantages that each stage has to offer. Adults and larvae of zebrafish are excellent models for researching epilepsy. Zebrafish larvae are easy to handle in a variety of experimental setups and are appropriate for high-throughput screening. However, because of their size, adults are more suitable for EEG, medication injection, dissection. There are several options available for chemical inducers employed in the zebrafish seizure model, each having a unique mechanism. Numerous parameters, including inflammation, oxidative damage, electrolyte imbalance, can be used to study the effects of seizures. PTZ is most utilized chemical in seizure research because of its well-described nature, validation by electrophysiological techniques, and availability in a range of doses. More research prospects are presented by broad topic that can be thoroughly studied, with many facets that are yet largely neglected, particularly in the situations of status epilepticus and temporal lobe epilepsy. These opportunities will help us understand the mechanics behind seizures at deeper level.

 

REFERENCES:

1.      Giourou E, Stavropoulou-Deli A, Giannakopoulou A, Kostopoulos GK, Koutroumanidis M. Introduction to Epilepsy   and Related Brain Disorders. In: Voros N, Antonopoulos C, editors. Cyberphysical Systems for Epilepsy and Related Brain Disorders. Cham: Springer; 2015.

2.      Subramanian S. Zebrafish as a model organism - can a fish mimic human? J Basic Clin Physiol Pharmacol. 2021; 34(5): 559-75.

3.      William R, Mruk K. Aquatic Freshwater Vertebrate Models of Epilepsy Pathology: Past Discoveries and Future Directions for Therapeutic Discovery. 2022.

4.      D’Amora M, Galgani A, Marchese M, Tantussi F, Faraguna U, De Angelis F, et al. Zebrafish as an Innovative Tool for Epilepsy Modeling: State of the Art and Potential Future Directions. Int J Mol Sci. 2023; 24(9): 7702.

5.      Dittmar F, Seyfried S, Kaever V, Seifert R. Zebrafish as model organism for cNMP research. BMC Pharmacol Toxicol. 2015; 16(1).

6.      Löscher W. Preclinical assessment of pro-convulsant drug activity and its relevance for predicting adverse events in humans. Eur J Pharmacol. 2009; 610(1-3): 1-11.

7.      Baraban SC, Taylor MR, Castro PA, Baier H. PTZ induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience. 2005; 131(3): 759-68.

8.      Baraban SC. A zebrafish-centric approach to antiepileptic drug development. Dis Model Mech. 2021;14.

9.      Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev Dyn. 1995; 203: 253-310.

10.   Streisinger G, Walker C, Dower N, Knauber D, Singer F. Production of clones of homozygous diploid zebra fish (Brachy danio rerio). Nature. 1981; 291: 293-296.

11.   D’Amora M, Schmidt TJN, Konstantinidou S, Raffa V, De Angelis F, Tantussi F. Effects of Metal Oxide Nanoparticles in Zebrafish. Oxid Med Cell Longev. 2022; 2022: 3313016.

12.   Geisler R, Köhler A, Dickmeis T, Strähle U. Archiving of zebrafish lines can reduce animal experiments in biomedical research. EMBO Rep. 2017; 18: 1-2.

13.   Patton EE, Zon LI, Langenau DM. Zebrafish disease models in drug discovery: From preclinical modelling to clinical trials. Nat Rev Drug Discov. 2021; 20: 611-28.

14.   Rinkwitz S, Mourrain P, Becker TS. Zebrafish: An integrative system for neurogenomics and neurosciences. Prog Neurobiol. 2011; 93: 231-43.

15.   Vaz R, Hofmeister W, Lindstrand A. Zebrafish Models of Neurodevelopmental Disorders: Limitations and Benefits of Current Tools and Techniques. Int J Mol Sci. 2019; 20(5): 1296.

16.   Diotel N, Lübke L, Strähle U, Rastegar S. Common and Distinct Features of Adult Neurogenesis and Regeneration in the Telencephalon of Zebrafish and Mammals. Front Neurosci. 2020; 14:568930.

17.   Becker TS, Rinkwitz S. Zebrafish as a genomics model for human neurological and polygenic disorders. Dev Neurobiol. 2012; 72: 415-28.

18.   Griffin A, Carpenter C, Liu J, Paterno R, Grone B, Hamling K, et al. Phenotypic analysis of catastrophic childhood epilepsy genes. Commun Biol. 2021; 4: 680.

19.   Grone BP, Baraban SC. Animal models in epilepsy research: Legacies and new directions. Nat Neurosci. 2015; 18: 339-43.

20.   Cho SJ, Park E, Baker A, Reid AY. Age bias in zebrafish models of epilepsy: What can we learn from old fish? Front Cell Dev Biol. 2020; 8: 573303.

21.   McMenamin SK, Parichy DM. Metamorphosis in teleosts. Curr Top Dev Biol. 2013; 103:127-65.

22.   Fleming A, Diekmann H, Goldsmith P. Functional Characterisation of the Maturation of the Blood-Brain Barrier in Larval Zebrafish. PLoS One. 2013; 8: e77548.

23.   Oby E, Janigro D. The Blood–Brain Barrier and Epilepsy. Epilepsia. 2006; 47: 1761-74.

24.   Duy PQ, Berberoglu MA, Beattie CE, Hall CW. Cellular responses to recurrent pentylenetetrazole-induced seizures in the adult zebrafish brain. Neuroscience. 2017; 349: 118-27.

25.   Fleming A, Diekmann H, Goldsmith P. Functional Characterisation of the Maturation of the Blood Brain Barrier in Larval Zebrafish. PLoS One. 2013; 8: e77548.

26.    Cho SJ, Park E, Baker A, Reid AY. Age bias in zebrafish models of epilepsy: What can we learn from old fish? Front Cell Dev Biol. 2020; 8: 573303.

27.   Mejías-Aponte CA, Jiménez-Rivera CA, Segarra AC. Sex differences in models of temporal lobe epilepsy: Role of testosterone. Brain Res. 2002; 944: 210-18.

28.   Scharfman HE, MacLusky NJ. Sex differences in the neurobiology of epilepsy: A preclinical perspective. Neurobiol Dis. 2014; 72: 180-92.

29.   Ampatzis K, Dermon CR. Sex differences in adult cell proliferation within the zebrafish (Danio rerio) cerebellum. Eur J Neurosci. 2007; 25: 1030-40.

30.   Ampatzis K, Dermon CR. Sexual dimorphisms in swimming behavior, cerebral metabolic activity, and adrenoceptors in adult zebrafish (Danio rerio). Behav Brain Res. 2016; 312: 385-93.

31.   Wong K, Stewart A, Gilder T, Wu N, Frank K, Gaikwad S, et al. Modeling seizure-related behavioral and endocrine phenotypes in adult zebrafish. Brain Res. 2010; 1348: 209-15.

32.   Braida D, Donzelli A, Martucci R, Ponzoni L, Pauletti A, Sala M. Neurohypophyseal hormones protect against pentylenetetrazole-induced seizures in zebrafish: Role of oxytocin-like and V1a-like receptor. Peptides. 2012; 37: 327-33.

33.   Cho SJ, Byun D, Nam TS, Choi SY, Lee BG, Kim MK, et al. Zebrafish as an animal model in epilepsy studies with multichannel EEG recordings. Sci Rep. 2017; 7: 3099.

34.   Aleshin VA, Graf AV, Artiukhov AV, Ksenofontov AL, Zavileyskiy LG, Maslova MV, et al. Pentylenetetrazole-Induced Seizures Are Increased after Kindling, Exhibiting Vitamin-Responsive Correlations to the Post-Seizures Behavior, Amino Acids Metabolism and Key Metabolic Regulators in the Rat Brain. Int J Mol Sci. 2023; 24(15): 12405.

35.   Al Omairi NE, Albrakati A, Alsharif KF, Almalki AS, Alsanie W, Abd Elmageed ZY, et al. Selenium Nanoparticles with Prodigiosin Rescue Hippocampal Damage Associated with Epileptic Seizures Induced by Pentylenetetrazole in Rats. Int J Mol Sci. 2023; 24(1): 157.

36.   Viswanatha GL, Shylaja H, Kishore DV, Venkataranganna M, Prasad N. Acteoside Isolated from Colebrookea oppositifolia Smith Attenuates Epilepsy in Mice Via Modulation of Gamma-Aminobutyric Acid Pathways. Neurotox Res. 2020; 38: 1010-23.

37.   Dhir A. Pentylenetetrazol (PTZ) kindling model of epilepsy. Curr Protoc Neurosci. 2012; 58(1): 9-37.

38.   D'Adamo MC, Catacuzzeno L, Di Giovanni G, Franciolini F, Pessia M. K+ channelepsy: progress in the neurobiology of potassium channels and epilepsy. Front Cell Neurosci. 2013; 7: 134.

39.   Gawel K, Kukula-Koch W, Nieoczym D, Stepnik K, van der Ent W, Banono NS, et al. The influence of palmatine isolated from Berberi’s sibirica radix on pentylenetetrazole-induced seizures in zebrafish. Cells. 2020; 9(5): 1233.

40.   Milder PC, Zybura AS, Cummins TR, Marrs JA. Neural Activity Correlates with Behavior Effects of Anti-Seizure Drugs Efficacy Using the Zebrafish Pentylenetetrazol Seizure Model. Front Pharmacol. 2022; 13: 836573.

41.   Gawel K, Kukula-Koch W, Nieoczym D, Stepnik K, van der Ent W, Banono NS, et al. The influence of palmatine isolated from Berberi’s sibirica radix on pentylenetetrazole-induced seizures in zebrafish. Cells. 2020; 9(5): 1233.

42.   Kundap UP, Kumari Y, Othman I, Shaikh MF. Zebrafish as a model for epilepsy-induced cognitive dysfunction: a pharmacological, biochemical, and behavioral approach. Front Pharmacol. 2017; 8: 515.

43.   Mussulini BH, Leite CE, Zenki KC, Moro L, Baggio S, Rico EP, et al. Seizures induced by pentylenetetrazole in the adult zebrafish: a detailed behavioral characterization. PLoS One. 2013; 8(1): e54515.

44.   Erkec ÖE, Arihan O. Pentylenetetrazole Kindling Epilepsy Model. Epilepsi. 2015; 21(1).

45.   Baraban SC, Taylor MR, Castro PA, Baier H. PTZ induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience. 2005; 131(3): 759-68.

46.   Chatterjee D, Tran S, Shams S, Gerlai R. A simple method for immunohistochemical staining of zebrafish brain sections for c-fos protein expression. Zebrafish. 2015; 12(6): 414-20.

47.   Aparicio SYL, Laureani Fierro ÁD, Aranda Abreu GE, Toledo Cárdenas R, García Hernández LI, Coria Ávila GA, et al. Current opinion on the use of c-fos in neuroscience. NeuroSci. 2022; 3(4): 687-702.

48.   Kovács KJ. Measurement of immediate‐early gene activation‐c‐fos and beyond. J Neuroendocrinol. 2008; 20(6): 665-72.

49.   Wang X, Hu Z, Zhong K. The role of brain-derived neurotrophic factor in epileptogenesis: An update. Front Pharmacol. 2021; 12: 758232.

50.   AlRuwaili R, Al-Kuraishy HM, Al-Gareeb AI, Ali NH, Alexiou A, Papadakis M, et al. The Possible Role of Brain-derived Neurotrophic Factor in Epilepsy. Neurochem Res. 2023: 1-5.

51.   Yogesh R. Joshi, Prabodh V. Sapkale, Pramod P. Patil. Effect of Nimodipine alone and in combination with Gabapentin against Pentylenetetrazole induced Seizures in Mice. Asian J. Pharm. Res. 2018; 8(4): 215-220.

52.   Jin M, Sheng W, Han L, He Q, Ji X, Liu K. Activation of bdnf-TrkB signaling pathway-regulated brain inflammation in pentylenetetrazole-induced seizures in zebrafish. Fish Shellfish Immunol. 2018; 83: 26-36.

53.   M. K. Senghani, P. M. Patel, G. Vidya Sagar. Anticonvulsant activity of boswellic acids against maximal electroshock- induced convulsive rats and picrotoxin- induced convulsive mice. Research Journal of Pharmacognosy and Phytochemistry. 2012; 4(6): 318-321.

54.   Shimada T, Yamagata K. Pentylenetetrazole-induced kindling mouse model. J Vis Exp. 2018;136: e56573.

55.   Wang X, Xiao A, Yang Y, Zhao Y, Wang CC, Wang Y, et al. DHA and EPA Prevent Seizure and Depression‐Like Behavior by Inhibiting Ferroptosis and Neuroinflammation via Different Mode‐of‐Actions in a Pentylenetetrazole‐Induced Kindling Model in Mice. Mol Nutr Food Res. 2022; 66(22): 2200275.

56.   Costa AM, Gol M, Lucchi C, Biagini G. Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy. Epilepsia. 2023; 64(5): 1376-89.

57.    Menezes FP, Rico EP, Da Silva RS. Tolerance to seizure induced by kainic acid is produced in a specific period of zebrafish development. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 55: 109-12.

58.    Mussulini BH, Vizuete AF, Braga M, Moro L, Baggio S, Santos E, et al. Forebrain glutamate uptake and behavioral parameters are altered in adult zebrafish after the induction of status epilepticus by kainic acid. Neurotoxicology. 2018; 67: 305-12.

59.    Heylen L, Pham DH, De Meulemeester AS, Samarut É, Skiba A, Copmans D, et al. Pericardial injection of kainic acid induces a chronic epileptic state in larval zebrafish. Front Mol Neurosci. 2021; 14: 753936.

60.    Goutman JD, Calvo DJ. Studies on the mechanisms of action of picrotoxin, quercetin and pregnanolone at the GABAρ1 receptor. Br J Pharmacol. 2004;141(4): 717-26.

61.    Santosh Kumar Panda, A. Venkateshwar Reddy, Mohammad Shamim Qureshi. Antiepileptogenic and Neuroprotective effects of Ziziphus jujuba leaves methanolic extract against pentylenetetrazole-induced kindling model in mice. Research J. Pharm. and Tech. 2018; 11(1): 259-266.

62.    M Kannadasan, Subal Debnath, Nilesh P Babre, P Parameshwar, VV Rajesham, Habibur rehman. Anti-Epileptic Activity of the Hydro-Alcoholic Extract of Erythrina fusca Lour. Bark through Behavioral Studies against the Animal Models of Epilepsy. Research J. Pharm. and Tech. 4(2): February 2011; Page 315-319.

63.   Basnet RM, Zizioli D, Taweedet S, Finazzi D, Memo M. Zebrafish larvae as a behavioral model in neuropharmacology. Biomedicines. 2019;7(1):23.

64.   Hashemi P, Moloudi MR, Vahabzadeh Z, Izadpanah E. Anticonvulsant Effects of Royal Jelly in Kainic Acid-Induced Animal Model of Temporal Lobe Epilepsy Through Antioxidant Activity. Drug Res. 2021;71(3):123-130.

65.   Yang X, Lin J, Peng X, Zhang Q, Zhang Y, Guo N, et al. Effects of picrotoxin on zebrafish larvae behaviors: A comparison study with PTZ. Epilepsy Behav. 2017; 70:224-231.

66.   Wong K, Stewart A, Gilder T, Wu N, Frank K, Gaikwad S, et al. Modeling seizure-related behavioral and endocrine phenotypes in adult zebrafish. Brain Res. 2010; 1348:209-215.

67.   Stankevicius D, Rodrigues-Costa EC, Flório JC, Palermo-Neto J. Neuroendocrine, behavioral and macrophage activity changes induced by picrotoxin effects in mice. Neuropharmacology. 2008;54(2):300-308.

68.   Baxendale S, Holdsworth CJ, Meza Santoscoy PL, Harrison MR, Fox J, Parkin CA, et al. Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures. Dis Model Mech. 2012;5(6):773-784.

69.   Sooraj Surendran, Merin Babu, Jipnomon Joseph, Uma Devi Padma. Facilitatory effect of Piperine on the Anticonvulsant effect of Sodium valproate against Pentylenetetrazole induced Seizures in mice. Research J. Pharm. and Tech 2020; 13(2):651-652.

70.   Juvale II, Hassan Z, Has AT. The emerging roles of π subunit-containing GABAA receptors in different cancers. Int J Med Sci. 2021;18(16):3851-3860.

71.   Scorza FA, Arida RM, Naffah-Mazzacoratti MD, Scerni DA, Calderazzo L, Cavalheiro EA. The pilocarpine model of epilepsy: what have we learned? An Acad Bras Cienc. 2009; 81:345-65.

72.   Hong S, Xin Y, JiaWen W, ShuQin Z, GuiLian Z, HaiQin W, et al. The P2X7 receptor in activated microglia promotes depression- and anxiety-like behaviors in lithium-pilocarpine induced epileptic rats. Neurochem Int. 2020; 138:104773.

73.   Paudel YN, Angelopoulou E, Akyuz E, Piperi C, Othman I, Shaikh MF. Role of innate immune receptor TLR4 and its endogenous ligands in epileptogenesis. Pharmacol Res. 2020; 160:105172.

74.   Vezzani A. Pilocarpine-induced seizures revisited: what does the model mimic? Epilepsy Curr. 2009;9(5):146-148.

75.   Vermoesen K, Serruys AS, Loyens E, Afrikanova T, Massie A, Schallier A, et al. Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models. Epilepsy Behav. 2011;22(3):450-460.

76.   Szep D, Dittrich B, Gorbe A, Szentpeteri JL, Aly N, Jin M, et al. A comparative study to optimize experimental conditions of pentylenetetrazol and pilocarpine-induced epilepsy in zebrafish larvae. PLoS One. 2023;18(7): e0288904.

77.   Alfaro JM, Ripoll-Gómez J, Burgos JS. Kainate administered to adult zebrafish causes seizures similar to those in rodent models. Eur J Neurosci. 2011;33(7):1252-1255.

78.   Copmans D, Siekierska A, de Witte PA. Zebrafish models of epilepsy and epileptic seizures. In: Models of Seizures and Epilepsy. 2017. p. 369-384.

79.   Lin TY, Hung CY, Chiu KM, Lee MY, Lu CW, Wang SJ. Neferine, an Alkaloid from Lotus Seed Embryos, Exerts Antiseizure and Neuroprotective Effects in a Kainic Acid-Induced Seizure Model in Rats. Int J Mol Sci. 2022;23(8):4130.

80.   Milder PC, Zybura AS, Cummins TR, Marrs JA. Neural Activity Correlates with Behavior Effects of Anti-Seizure Drugs Efficacy Using the Zebrafish Pentylenetetrazol Seizure Model. Front Pharmacol. 2022; 13:836573.

81.   Baraban SC, Taylor MR, Castro PA, Baier H. PTZ induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience. 2005; 131:759-768.

82.   Kim Y, Lee Y, Lee H, Jung MW, Lee C. Impaired avoidance learning and increased hsp70 mRNA expression in pentylenetetrazol-treated zebrafish. Anim Cells Syst. 2009; 13:275-281.

83.   Goldsmith P, Golder Z, Hunt J, Berghmans S, Jones D, Stables JP, et al. GBR12909 possesses anticonvulsant activity in zebrafish and rodent models of generalized epilepsy but cardiac ion channel effects limit its clinical utility. Pharmacology. 2007; 79:250-258.

84.   Alfaro JM, Ripoll-Gómez J, Burgos JS. Kainate administered to adult zebrafish causes seizures similar to those in rodent models. Eur J Neurosci. 2011; 33:1252-1255.

 

 

 

 

Received on 08.08.2025      Revised on 18.09.2025

Accepted on 22.10.2025      Published on 12.02.2026

Available online from February 14, 2026

Res.J. Pharmacology and Pharmacodynamics.2026;18(1):7-14.

DOI: 10.52711/2321-5836.2026.00002

©A and V Publications All right reserved

 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.